TDOC Teladoc Health, Inc. Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 30, 2026TDOC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
TDOC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Teladoc Health, Inc. Common Stock Descripción general de la empresa de Wikipedia
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.
History
2002–2015
Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.
Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.
2015–2016
Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.
In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.
In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.
2017–2020
In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.
On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.
Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.
In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.
2021–2024
In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.
On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.
Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.
In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.
In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.
2025–present
In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.
In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.
The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.
Services and business model
Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.
Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.
By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.
Disaster aid
Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.
Lobbying and legislation
Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.
In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.
In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TDOC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -5.6promedio 5A ≈-11.5 | ≈-11.5 | · | · | |
| P/S (TTM) | 0.4promedio 5A ≈2.3 | ≈2.3 | 2.5 | Infravalorado | |
| P/C (MRQ) | 0.8promedio 5A ≈1.2 | ≈1.2 | 2.9 | Infravalorado | |
| Precio / FCF (TTM) | 4.0promedio 5A ≈24.5 | ≈24.5 | · | · | |
| Precio / Flujo de Caja (TTM) | 3.8promedio 5A ≈23.2 | ≈23.2 | 12.7 | Infravalorado | |
| Precio / Valor Contable Tangible (MRQ) | 7.5 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TDOC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -7.5%promedio 5A ≈-128.0% | ≈-128.0% | -0.21% | Débil | |
| EBITDA Margin (Margen EBITDA) | -10.4%promedio 5A ≈-123.9% | ≈-123.9% | -0.21% | Débil | |
| Margen antes de impuestos (TTM) | -7.3%promedio 5A ≈-128.6% | ≈-128.6% | 2.5% | Débil | |
| Margen de Beneficio Neto (TTM) | -7.1%promedio 5A ≈-128.8% | ≈-128.8% | 1.5% | Débil | |
| ROA (TTM) | -6.3%promedio 5A ≈-32.6% | ≈-32.6% | -0.10% | Débil | |
| ROE (TTM) | -13.0%promedio 5A ≈-84.0% | ≈-84.0% | 0.73% | Débil | |
| ROIC | -16.1%promedio 5A ≈-137.8% | ≈-137.8% | -0.32% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TDOC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 0.8promedio 5A ≈3.0 | ≈3.0 | 1.8 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 2.4promedio 5A ≈2.6 | ≈2.6 | 1.1 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TDOC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -1.5%promedio 5A ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 1.7%promedio 5A ≈14.4% | ≈14.4% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 18.3% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TDOC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.8promedio 5A ≈0.5 | ≈0.5 | 0.6 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 12.4promedio 5A ≈12.2 | ≈12.2 | 5.2 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$544.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 27, 2026 | $-0.21 | $-0.25 | 17.6% |
| 31 de marzo de 2026 | $-0.36 | $-0.32 | -12.6% | |
| 31 de diciembre de 2025 | $-0.14 | $-0.19 | 26.9% | |
| 30 de septiembre de 2025 | $-0.28 | $-0.27 | -3.2% | |
| 30 de junio de 2025 | $-0.19 | $-0.27 | 28.7% | |
| 31 de marzo de 2025 | $-0.53 | $-0.34 | -54.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.77 | $8.60 | $13.96 | $14.17 | $99.99 | $105.69 | $13.94 | $14.37 | $9.08 | · | $4.63 | · | |
| Revenue / Share | $14.36 | $15.07 | $15.81 | $14.91 | $12.95 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $1.67 | $1.72 | $2.13 | $1.17 | $1.24 | · | · | · | · | · | · | · | |
| Cash / Share | $4.38 | $7.49 | $6.74 | $5.64 | $5.57 | $4.88 | $7.07 | $6.01 | $0.70 | · | $1.43 | · | |
| EPS (TTM) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | · | 176,934,781 | 175,917,380 | 174,154,128 | · | 171,496,282 | 170,229,583 | 167,730,746 | · | 165,119,379 | 164,171,372 | 162,922,691 | · | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | · | 176,934,781 | 175,917,380 | 174,154,128 | · | 171,496,282 | 170,229,583 | 167,730,746 | · | 165,119,379 | 164,171,372 | 162,922,691 | · | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.21 | $7.41 | · | $7.85 | $8.05 | $8.14 | · | $8.77 | $8.78 | $13.52 | · | $13.86 | $13.92 | $13.98 | · | $37.32 | |
| Revenue / Share | $3.35 | $3.43 | · | $3.54 | $3.59 | $3.61 | · | $3.73 | $3.77 | $3.85 | · | $4.00 | $3.97 | $3.86 | · | $3.78 | |
| Cash Flow / Share | · | $0.05 | · | · | · | $0.09 | · | · | · | $0.05 | · | · | · | $0.08 | · | · | |
| Cash / Share | $4.26 | $4.16 | · | $4.09 | $3.85 | $6.81 | · | $7.23 | $6.79 | $6.48 | · | $6.22 | $5.81 | $5.42 | · | $5.55 | |
| EPS (TTM) | $-0.99 | $-0.97 | · | $-1.27 | $-1.18 | $-5.91 | · | $-5.77 | $-5.93 | $-1.41 | · | $-24.52 | $-24.62 | $-43.44 | · | $-61.28 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.49B | $2.51B | · | $2.53B | $2.54B | $2.55B | · | $2.59B | $2.61B | $2.62B | · | $2.58B | $2.53B | $2.47B | · | $2.32B | |
| Net Income TTM | $-177M | $-171M | · | $-224M | $-207M | $-1.01B | · | $-982M | $-1.01B | $-233M | · | $-4.00B | $-4.02B | $-7.05B | · | $-9.86B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.6 | -5.6 | · | -6.1 | -7.4 | -1.3 | · | -1.6 | -1.6 | -10.7 | · | -0.8 | -1.0 | -0.6 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.6 | 1.7 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| Earnings Yield | -11.7% | -17.8% | · | -16.4% | -13.6% | -74.2% | · | -62.8% | -60.6% | -9.3% | · | -131.9% | -97.2% | -167.7% | · | -241.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Margen Operativo % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| Beneficio neto | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| EPS Diluido | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | · | · | · | 0.0 |
| Ratio corriente | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| Ratio Rápido | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $285M | $283M | $339M | $173M | $185M |
Propietarios institucionales (13F) 392 declarantes · $1.5B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 65 (-2 vs trimestre anterior) | 34 (-38 vs trimestre anterior) | 111 (-8 vs trimestre anterior) | 94 (+9 vs trimestre anterior) | +11.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $150 385 949 | 21 483 707 | 9,91% | Acciones |
| BlackRock, Inc. | $137 572 176 | 16 223 134 | 9,07% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107 573 820 | 12 685 592 | 7,09% | Acciones |
| Point72 Asset Management, L.P. | $69 874 581 | 8 239 927 | 4,61% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $68 457 700 | 8 072 842 | 4,51% | Acciones |
| Voss Capital, LP | $68 235 838 | 8 046 679 | 4,50% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $67 458 671 | 7 955 032 | 4,45% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $62 515 646 | 7 371 699 | 4,12% | Acciones |
| STATE STREET CORP | $42 080 999 | 4 962 382 | 2,77% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $41 505 394 | 4 894 504 | 2,74% | Acciones |
| Allianz Asset Management GmbH | $39 572 734 | 4 666 596 | 2,61% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $39 472 353 | 4 653 834 | 2,60% | Acciones |
| GOLDMAN SACHS GROUP INC | $32 412 969 | 3 822 284 | 2,14% | Acciones |
| Monaco Asset Management SAM | $26 864 462 | 3 167 979 | 1,77% | Acciones |
| JUPITER ASSET MANAGEMENT LTD | $26 370 375 | 3 109 714 | 1,74% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25 976 377 | 3 063 252 | 1,71% | Acciones |
| Quantinno Capital Management LP | $23 904 416 | 2 818 917 | 1,58% | Acciones |
| FEDERATED HERMES, INC. | $18 037 027 | 2 127 008 | 1,19% | Acciones |
| UBS Group AG | $17 401 181 | 2 052 026 | 1,15% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17 299 632 | 2 040 051 | 1,14% | Acciones |
| AMERIPRISE FINANCIAL INC | $16 998 584 | 2 004 550 | 1,12% | Acciones |
| Pale Fire Capital SE | $16 737 502 | 1 973 762 | 1,10% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16 435 088 | 1 938 100 | 1,08% | Opción de compra |
| NORTHERN TRUST CORP | $15 055 374 | 1 775 398 | 0,99% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $14 855 924 | 1 751 878 | 0,98% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 710 032 | 1 380 900 | 0,77% | Opción de venta |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11 348 708 | 1 338 291 | 0,75% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 229 479 | 1 324 231 | 0,74% | Acciones |
| MORGAN STANLEY | $11 055 129 | 1 303 670 | 0,73% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $10 120 074 | 1 193 405 | 0,67% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $9 796 800 | 1 155 283 | 0,65% | Acciones |
| FRANKLIN RESOURCES INC | $9 710 439 | 1 145 099 | 0,64% | Acciones |
| Allspring Global Investments Holdings, LLC | $9 024 853 | 991 742 | 0,59% | Acciones |
| Freestone Grove Partners LP | $7 338 160 | 865 349 | 0,48% | Acciones |
| Man Group plc | $6 880 545 | 811 385 | 0,45% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $6 827 859 | 805 172 | 0,45% | Acciones |
| CITADEL ADVISORS LLC | $6 795 024 | 801 300 | 0,45% | Opción de venta |
| Union Square Park Capital Management, LLC | $6 784 000 | 800 000 | 0,45% | Acciones |
| CITADEL ADVISORS LLC | $6 532 093 | 770 294 | 0,43% | Acciones |
| FMR LLC | $6 449 076 | 760 504 | 0,43% | Acciones |
| TCW GROUP INC | $6 248 039 | 736 797 | 0,41% | Acciones |
| Voss Capital, LP | $5 936 000 | 700 000 | 0,39% | Opción de compra |
| Empowered Funds, LLC | $5 764 619 | 679 790 | 0,38% | Acciones |
| Bank of New York Mellon Corp | $5 535 043 | 652 717 | 0,36% | Acciones |
| D. E. Shaw & Co., Inc. | $5 420 493 | 639 209 | 0,36% | Acciones |
| PEAK6 LLC | $5 227 920 | 616 500 | 0,34% | Opción de compra |
| CITADEL ADVISORS LLC | $5 114 288 | 603 100 | 0,34% | Opción de compra |
| Squarepoint Ops LLC | $5 089 696 | 600 200 | 0,34% | Opción de compra |
| JANE STREET GROUP, LLC | $5 088 848 | 600 100 | 0,34% | Opción de venta |
| JPMORGAN CHASE & CO | $4 283 818 | 484 856 | 0,28% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 presentaciones | 15 de abril de 2021 | · | Presentación inicial | · | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 presentaciones | 16 de marzo de 2021 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 56 insiders · 29 directivos · 24 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 10 de septiembre de 2026 M | 465 535 | 0 | 7 | $-1 035 229 |
| Laizer Kornwasser | Advisor to the CEO | 1 de agosto de 2024 M | 99 929 | 0 | 0 | $0 |
| Jason N Gorevic | CHIEF EXECUTIVE OFFICER | 19 de marzo de 2024 A | 653 073 | 0 | 0 | $0 |
| Michael F Grasher | Chief Financial Officer | 1 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Mala Murthy | CHIEF FINANCIAL OFFICER | 29 de agosto de 2025 M | 142 385 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 13 de diciembre de 2018 M | 10 000 | 0 | 0 | $0 |
| Carlos Nueno | President, International | 1 de septiembre de 2026 M | 64 744 | 0 | 4 | $-218 769 |
| Fernando M. Rodrigues | President of BetterHelp | 1 de septiembre de 2026 M | 0 | 0 | 8 | $-469 637 |
| Kelly Bliss | President, U.S. Group Health | 1 de septiembre de 2026 M | 92 832 | 0 | 7 | $-343 192 |
| Peter A Mcclennen | President | 15 de julio de 2019 M | 0 | 0 | 0 | $0 |
| Michael Willem Waters | CHIEF OPERATING OFFICER | 30 de agosto de 2024 M | 78 309 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 29 de julio de 2021 M | 11 031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 1 de septiembre de 2026 M | 12 865 | 0 | 7 | $-48 940 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 1 de septiembre de 2026 M | 117 616 | 0 | 4 | $-289 541 |
| Vidya Raman-Tangella | CHIEF MEDICAL OFFICER | 4 de septiembre de 2024 S | 33 665 | 0 | 0 | $0 |
| Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 4 de septiembre de 2024 S | 20 773 | 0 | 0 | $0 |
| James L. Cave | INTERIM CAO | 30 de agosto de 2024 M | 13 808 | 0 | 0 | $0 |
| Nikolaos P. Nanis | Chief Technology Officer | 30 de agosto de 2024 M | 75 410 | 0 | 0 | $0 |
| Arnnon Geshuri | CHIEF PEOPLE OFFICER | 30 de agosto de 2024 M | 44 914 | 0 | 0 | $0 |
| Daniel Trencher | CHIEF STRATEGY OFFICER | 30 de agosto de 2024 M | 31 465 | 0 | 0 | $0 |
| Stephany Verstraete | CHIEF MARKETING OFFICER | 30 de agosto de 2024 M | 48 843 | 0 | 0 | $0 |
| Richard J Napolitano | CHIEF ACCOUNTING OFFICER | 19 de marzo de 2024 A | 18 077 | 0 | 0 | $0 |
| Claus Torp Jensen | CHIEF INNOVATION OFFICER | 1 de diciembre de 2023 M | 20 703 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 1 de octubre de 2020 M | 8 766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 1 de septiembre de 2020 M | 3 232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 1 de julio de 2020 A | · | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 16 de abril de 2020 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 25 de mayo de 2017 A | 61 459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 13 de marzo de 2017 A | · | 0 | 0 | $0 |
| Mark V Anquillare | Consejero | 3 de agosto de 2026 A | · | 0 | 0 | $0 |
| Catherine Jacobson | Consejero | 21 de mayo de 2026 A | 66 853 | 0 | 0 | $0 |
| Mark Douglas Smith | Consejero | 21 de mayo de 2026 A | 8 355 | 0 | 0 | $0 |
| Kenneth H Paulus | Consejero | 21 de mayo de 2026 A | 10 000 | 1 | 0 | $69 400 |
| David B Snow JR | Consejero | 21 de mayo de 2026 A | 113 032 | 0 | 0 | $0 |
| David L Shedlarz | Consejero | 21 de mayo de 2026 A | 61 266 | 0 | 0 | $0 |
| Susan R Salka | Consejero | 30 de marzo de 2026 A | · | 0 | 0 | $0 |
| Michael S Smith | Consejero | 18 de febrero de 2026 A | · | 0 | 0 | $0 |
| Jason Eric Evans | Consejero | 19 de diciembre de 2025 M | 9 145 | 0 | 0 | $0 |
| Thomas Mckinley | Consejero | 22 de mayo de 2025 A | 56 544 | 0 | 0 | $0 |
| Karen L Daniel | Consejero | 22 de mayo de 2024 M | 36 995 | 0 | 0 | $0 |
| William H. Frist | Consejero | 26 de mayo de 2022 A | 12 918 | 0 | 0 | $0 |
| Christopher Bischoff | Consejero | 17 de mayo de 2022 M | 7 195 | 0 | 0 | $0 |
| Hemant Taneja | Consejero | 19 de abril de 2021 S | 118 760 | 0 | 0 | $0 |
| Glen Tullman | Consejero | 1 de abril de 2021 M | 275 793 | 0 | 0 | $0 |
| Helen Darling | Consejero | 11 de junio de 2020 M | 918 | 0 | 0 | $0 |
| Arneek Multani | Consejero | 30 de mayo de 2019 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | Consejero | 30 de mayo de 2019 A | 1 965 | 0 | 0 | $0 |
| Tom Mawhinney | Consejero | 25 de mayo de 2018 M | 46 203 | 0 | 0 | $0 |
| Martin R Felsenthal | Consejero | 8 de agosto de 2016 A | 10 860 | 0 | 0 | $0 |
| Dana G Mead Jr. | Consejero | 8 de agosto de 2016 A | 202 | 0 | 0 | $0 |
| James K Outland | Consejero | 13 de julio de 2015 M | 49 986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | Propietario del 10% | 26 de abril de 2017 J | 2 480 468 | 0 | 0 | $0 |
| CHP III LP | Propietario del 10% | 26 de abril de 2017 J | 2 480 468 | 0 | 0 | $0 |
| Sandra L Fenwick | · | 21 de mayo de 2026 A | 12 070 | 0 | 0 | $0 |
| Yulun Wang | · | 25 de enero de 2021 S | 219 507 | 0 | 0 | $0 |
| Michael Goldstein | · | 11 de junio de 2020 M | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 37 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IHF · iShares Trust | 0,16% | 347 966 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,10% | 159 976 SH | 19 de agosto de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,08% | 1 038 485 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1 047 849 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,05% | 219 811 SH | 11 de septiembre de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 47 383 NS | 31 de julio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,04% | 29 737 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,04% | 87 202 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 4 676 471 SH | 11 de septiembre de 2026 | Diario |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2 631 374 SH | 19 de agosto de 2026 | Diario |
| PNQI · Invesco Exchange-Traded Fund Trust | 0,03% | 27 091 SH | 1 de octubre de 2026 | Diario |
| DFAT · Dimensional ETF Trust | 0,02% | 528 876 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2 084 219 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,02% | 4 153 113 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,02% | 535 056 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 83 458 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 325 784 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 11 242 NS | 31 de julio de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 176 576 SH | 1 de octubre de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 10 496 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 21 330 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 449 072 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 18 459 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 23 195 NS | 31 de julio de 2026 | N-PORT |
| DSI · iShares Trust | 0,00% | 25 114 SH | 10 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 82 328 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 43 186 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 232 868 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 45 761 SH | 3 de septiembre de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,00% | 16 298 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5 687 282 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 15 175 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 1 697 159 SH | 11 de septiembre de 2026 | Diario |
| SVAL · iShares Trust | · | 100 159 SH | 3 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 7 717 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 38 629 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 597 716 SH | 11 de septiembre de 2026 | Diario |
TDOC Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
17 analistas · 2026-10-02Objetivo medio $7.68 +39,1%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | · |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.